Literature DB >> 18287563

The death ligand TRAIL in diabetic nephropathy.

Corina Lorz1, Alberto Benito-Martín, Anissa Boucherot, Alvaro C Ucero, Maria Pia Rastaldi, Anna Henger, Silvia Armelloni, Beatriz Santamaría, Celine C Berthier, Matthias Kretzler, Jesus Egido, Alberto Ortiz.   

Abstract

Apoptotic cell death contributes to diabetic nephropathy (DN), but its role is not well understood. The tubulointerstitium from DN biopsy specimens was microdissected, and expression profiles of genes related to apoptosis were analyzed. A total of 112 (25%) of 455 cell death-related genes were found to be significantly differentially regulated. Among those that showed the greatest changes in regulation were two death receptors, OPG (the gene encoding osteoprotegerin) and Fas, and the death ligand TRAIL. Glomerular and proximal tubular TRAIL expression, assessed by immunohistochemistry, was higher in DN kidneys than controls and was associated with clinical and histologic severity of disease. In vitro, proinflammatory cytokines but not glucose alone regulated TRAIL expression in the human proximal tubular cell line HK-2. TRAIL induced tubular cell apoptosis in a dosage-dependant manner, an effect that was more marked in the presence of high levels of glucose and proinflammatory cytokines. TRAIL also activated NF-kappaB, and inhibition of NF-kappaB sensitized cells to TRAIL-induced apoptosis. It is proposed that TRAIL-induced cell death could play an important role in the progression of human DN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287563      PMCID: PMC2386716          DOI: 10.1681/ASN.2007050581

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

Authors:  J G Emery; P McDonnell; M B Burke; K C Deen; S Lyn; C Silverman; E Dul; E R Appelbaum; C Eichman; R DiPrinzio; R A Dodds; I E James; M Rosenberg; J C Lee; P R Young
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

2.  Characterization of two receptors for TRAIL.

Authors:  P Schneider; J L Bodmer; M Thome; K Hofmann; N Holler; J Tschopp
Journal:  FEBS Lett       Date:  1997-10-27       Impact factor: 4.124

3.  Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group.

Authors:  C M Mangano; L S Diamondstone; J G Ramsay; A Aggarwal; A Herskowitz; D T Mangano
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

4.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.

Authors:  P Schneider; M Thome; K Burns; J L Bodmer; K Hofmann; T Kataoka; N Holler; J Tschopp
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  Role of Bcl-xL in paracetamol-induced tubular epithelial cell death.

Authors:  Corina Lorz; Pilar Justo; Ana Belén Sanz; Jesús Egido; Alberto Ortíz
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

Review 6.  The Fas ligand/Fas system in renal injury.

Authors:  A Ortiz; C Lorz; J Egido
Journal:  Nephrol Dial Transplant       Date:  1999-08       Impact factor: 5.992

7.  Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways.

Authors:  K H Moley; M M Chi; C M Knudson; S J Korsmeyer; M M Mueckler
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

8.  Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.

Authors:  M Ruiz-Ortega; C Bustos; M A Hernández-Presa; O Lorenzo; J J Plaza; J Egido
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.

Authors:  Kosaku Nitta; Takashi Akiba; Keiko Uchida; Akira Kawashima; Wako Yumura; Takashi Kabaya; Hiroshi Nihei
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

10.  Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy.

Authors:  Katalin Susztak; Emilio Ciccone; Peter McCue; Kumar Sharma; Erwin P Böttinger
Journal:  PLoS Med       Date:  2005-02-22       Impact factor: 11.069

View more
  42 in total

1.  Pirfenidone for diabetic nephropathy.

Authors:  Kumar Sharma; Joachim H Ix; Anna V Mathew; Monique Cho; Axel Pflueger; Stephen R Dunn; Barbara Francos; Shoba Sharma; Bonita Falkner; Tracy A McGowan; Michael Donohue; Satish Ramachandrarao; Ronghui Xu; Fernando C Fervenza; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.

Authors:  Marie-Luise Brezniceanu; Cara J Lau; Nicolas Godin; Isabelle Chénier; Alain Duclos; Jean Ethier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 10.121

Review 3.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

Review 4.  Inflammation in diabetic kidney disease.

Authors:  Patricia M García-García; María A Getino-Melián; Virginia Domínguez-Pimentel; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2014-08-15

5.  Use of Proteomics To Investigate Kidney Function Decline over 5 Years.

Authors:  Axel C Carlsson; Erik Ingelsson; Johan Sundström; Juan Jesus Carrero; Stefan Gustafsson; Tobias Feldreich; Markus Stenemo; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-21       Impact factor: 8.237

6.  Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.

Authors:  Alberto J López-Jiménez; Trayambak Basak; Roberto M Vanacore
Journal:  J Biol Chem       Date:  2017-09-01       Impact factor: 5.157

7.  Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

Authors:  Khondoker M Akram; Nicola J Lomas; Nicholas R Forsyth; Monica A Spiteri
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 8.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

Review 9.  Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge.

Authors:  Sebastian Martini; Felix Eichinger; Viji Nair; Matthias Kretzler
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

Review 10.  The role of reactive oxygen species in apoptosis of the diabetic kidney.

Authors:  F A D T G Wagener; D Dekker; J H Berden; A Scharstuhl; J van der Vlag
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.